XTX Topco »

Rapport Therapeutics shares owned by XTX Topco

Quarter-by-quarter ownership of Rapport Therapeutics (RAPP) shares owned by XTX Topco from 13F filings

Historical chart of XTX Topco investment in Rapport Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Rapport Therapeutics held by XTX Topco consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rapport Therapeutics by XTX Topco

Quarter filed Position value Share count Share price at filing
2025-12-31 $396k 13k 30.34
2025-03-31 $155k 15k 10.03

More positions owned by XTX Topco

Procter & Gamble Company (PG)
JPMorgan Chase & Co. (JPM)
NVIDIA Corporation (NVDA)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Apple (AAPL)
Cme (CME)
Kroger (KR)
At&t (T)
Vanguard Index Fds Total Stk Mkt (VTI)
Metropcs Communications (TMUS)
First Ctzns Bancshares Inc D Cl A (FCNCA)
S&p Global (SPGI)
Albertsons Cos Common Stock (ACI)
O'reilly Automotive (ORLY)
Owl Rock Capital Corporation (OBDC)

View all positions for XTX Topco

Top funds holding Rapport Therapeutics

TRV GP V
FMR
Arch Venture Corp
Capital Research and Management Company - Division 3
Cormorant Asset Management
Goldman Sachs Group
BlackRock
Sofinnova Ventures
Vanguard Group
Johnson & Johnson
Baker Bros. Advisors
Vestal Point Capital
Polar Capital Holdings
Trv Gp Vi
Ubs Global Asset Management Americas

View all funds holding Rapport Therapeutics